Henry J. Renk

Henry J. Renk

Of Counsel, New York

In almost 40 years with Fitzpatrick, Henry has amassed expertise in litigating complex patent infringement cases in the federal courts, including in the district courts and the Court of Appeals for the Federal Circuit. He has been lead counsel for many clients and has been trial counsel for many others.

Mr. Renk was formerly an adjunct Professor of Law at Pace University School of Law in White Plains, New York, where he taught Patent Law.

Case Highlight
AstraZeneca Pharms. LP, et al. v. Anchen Pharms, Inc., et al.
Fed. Cir. (2013)

Lead counsel in a successful patent infringement trial for AstraZeneca against a number of generic drug companies regarding AstraZeneca's patent covering its very successful Seroquel XR® antipsychotic drug, and he led a team in the Federal Circuit that obtained a per curiam affirmance of the district court judgment. Earlier, Mr. Renk was lead counsel for AstraZeneca in a patent infringement case against generic drug companies involving AstraZeneca's patent protecting its blockbuster Seroquel® antipsychotic drug. A district court summary judgment in AstraZeneca's favor was affirmed on appeal.
What Others Say
  • [considered by rivals as] “a big name in litigation” (LMG Life Sciences 2013)
  • “Henry's knowledge and experience in patent litigation is beyond reproach. He is a highly effective and respected patent litigation attorney who has great standing among his peers. I can highly recommend Henry to other prospective clients without any reservations” (Best Lawyers in America 2014)
  • [provides] “practical solutions to difficult problems” (Legal 500 2013)
  • “strategic minded” and [has] deep understanding of the Hatch-Waxman Act” (IAM 250 Life Sciences 2010)
  • “keystone of this great bench of lawyers” (IAM 250 The World’s Leading Patent Litigators 2011)
Events / Publications
News & Press